Skip to main content
SCLX
NASDAQ Life Sciences

Scilex Holding Co. Revokes Preferred Stock Dividend, Eliminates Series 1 Preferred Shares

Analysis by Wiseek AI
Sentiment info
Neutral
Importance info
7
Price
$8.81
Mkt Cap
$74.808M
52W Low
$3.6
52W High
$34.27
Market data snapshot near publication time

Summary

Scilex Holding Co. has revoked a long-delayed preferred stock dividend and eliminated the associated Series 1 Mandatory Exchangeable Preferred Stock, simplifying its capital structure.


Key Events

  • Dividend Revocation Approved

    The Board of Directors formally approved the revocation of a previously declared stock dividend consisting of 5,000,000 shares of Series 1 Mandatory Exchangeable Preferred Stock.

  • Preferred Stock Designation Eliminated

    A Certificate of Elimination was filed with the State of Delaware, removing the designation of Series 1 Mandatory Exchangeable Preferred Stock and returning these shares to undesignated status.

  • Capital Structure Clarified

    No Series 1 Preferred Stock was ever issued, and this action removes a potential future dilutive overhang, providing clarity to the company's capital structure.


Analysis

Scilex Holding Company's Board of Directors has officially revoked a previously declared stock dividend of 5,000,000 shares of Series 1 Mandatory Exchangeable Preferred Stock. This dividend, initially declared in October 2024, had faced multiple postponements and was never issued. The subsequent filing of a Certificate of Elimination formally removes the designation of these preferred shares, returning them to undesignated status. This action clarifies the company's capital structure and removes a long-standing potential source of future dilution, which could be viewed positively by investors seeking certainty. This follows closely on the heels of a significant strategic investment announced yesterday, suggesting a broader effort to streamline capital management.

At the time of this filing, SCLX was trading at $8.81 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $74.8M. The 52-week trading range was $3.60 to $34.27. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SCLX - Latest Insights

SCLX
Jun 02, 2026, 5:09 PM EDT
Filing Type: S-3
Importance Score:
9
Price at Filing: $7.40
Real-time Price: $8.59 info
Change: +$1.19 (+16%) info
Market Cap: $72.176M info
SCLX
May 20, 2026, 5:22 PM EDT
Filing Type: 10-Q
Importance Score:
10
Price at Filing: $6.01
Real-time Price: $8.59 info
Change: +$2.58 (+43%) info
Market Cap: $72.176M info
SCLX
May 05, 2026, 4:05 PM EDT
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $10.83
Real-time Price: $8.59 info
Change: -$2.24 (-21%) info
Market Cap: $72.176M info
SCLX
May 05, 2026, 1:24 PM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $11.00
Real-time Price: $8.59 info
Change: -$2.41 (-22%) info
Market Cap: $72.176M info
SCLX
May 05, 2026, 1:00 PM EDT
Source: GlobeNewswire
Importance Score:
10
Price at Filing: $11.49
Real-time Price: $8.59 info
Change: -$2.91 (-25%) info
Market Cap: $72.176M info
SCLX
Apr 30, 2026, 4:55 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $10.50
Real-time Price: $8.59 info
Change: -$1.91 (-18%) info
Market Cap: $72.176M info
SCLX
Apr 28, 2026, 4:58 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $7.25
Real-time Price: $8.59 info
Change: +$1.34 (+18%) info
Market Cap: $72.176M info
SCLX
Apr 27, 2026, 10:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
10
Price at Filing: $6.82
Real-time Price: $8.59 info
Change: +$1.77 (+26%) info
Market Cap: $72.176M info
SCLX
Apr 20, 2026, 8:56 AM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $7.00
Real-time Price: $8.59 info
Change: +$1.59 (+23%) info
Market Cap: $72.176M info
SCLX
Apr 20, 2026, 8:52 AM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $7.00
Real-time Price: $8.59 info
Change: +$1.59 (+23%) info
Market Cap: $72.176M info